← Leaderboards
Joel S Schuman
Tufts Medical Center
$19,163,581
Attributed
$22,094,832
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,094,832 · 5
By mechanism
R01$18,282,518 · 2
U01$3,200,220 · 1
P30$612,094 · 2
Top collaborators
- Jay Duker5 shared
- James G Fujimoto5 shared
- Hao F Zhang5 shared
Most similar at Tufts Medical Center
Same institution · by research overlap
- Jennifer K. Chow$875,954
- Ira M Herman$4,811,085
Others in their field
Top investigators on “Structure”
- David Heimbrook · Leidos Biomedical Research, Inc.$475,333,582
- Barton F Haynes · Duke University$444,977,767
- Lawrence Corey · Fred Hutchinson Cancer Center$334,646,086
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$315,257,203
Research focus
StructureGlaucomaTechnologyMeasurementScanningImaging TechnologyEarly DiagnosisOptical Coherence TomographyImageClinical ResearchDetectionTissuesRetinaProgramsResearch StudyThickInnovationDisease ProgressionResolutionCohortSourceDesignDiagnosticEvaluation
Grant awards (42)
Novel Glaucoma Diagnostics for Structure and Function.$1,047,658
R01 · FY2025 · EY · contact PI
Clinical glaucoma management enabled by visible-light OCT$619,124
U01 · FY2025 · EY
Core Vision Grant - Translational Research$107,274
P30 · FY2025 · EY · contact PI
Novel Glaucoma Diagnostics for Structure and Function.$1,308,371
R01 · FY2024 · EY · contact PI
Clinical glaucoma management enabled by visible-light OCT$619,124
U01 · FY2024 · EY
Novel Glaucoma Diagnostics for Structure and Function - Renewal - 1$687,519
R01 · FY2023 · EY · contact PI
Clinical glaucoma management enabled by visible-light OCT$631,924
U01 · FY2023 · EY
Core Vision Grant - Translational Research$126,205
P30 · FY2023 · EY · contact PI
Novel Glaucoma Diagnostics for Structure and Function - Renewal - 1$666,893
R01 · FY2022 · EY · contact PI
Clinical glaucoma management enabled by visible-light OCT$631,924
U01 · FY2022 · EY
Core Vision Grant - Translational Research$126,205
P30 · FY2022 · EY · contact PI
Clinical glaucoma management enabled by visible-light OCT$698,124
U01 · FY2021 · EY
Novel Glaucoma Diagnostics for Structure and Function - Renewal - 1$666,892
R01 · FY2021 · EY · contact PI
Core Vision Grant - Translational Research$126,205
P30 · FY2021 · EY · contact PI
Novel Glaucoma Diagnostics for Structure and Function - Renewal - 1$687,519
R01 · FY2020 · EY · contact PI
Novel Glaucoma Diagnostics for Structure and Function - Renewal - 1$299,601
R01 · FY2020 · EY · contact PI
Core Vision Grant - Translational Research$126,205
P30 · FY2020 · EY · contact PI
Novel Glaucoma Diagnostics for Structure and Function - Renewal - 1$715,489
R01 · FY2019 · EY · contact PI
Novel Diagnostics with Optical Coherence Tomography$432,875
R01 · FY2019 · EY
Novel Glaucoma Diagnostics for Structure and Function$648,960
R01 · FY2018 · EY · contact PI
Novel Diagnostics with Optical Coherence Tomography$426,812
R01 · FY2018 · EY
Novel Glaucoma Diagnostics for Structure and Function$654,143
R01 · FY2017 · EY · contact PI
Novel Diagnostics with Optical Coherence Tomography$439,008
R01 · FY2017 · EY
Novel Glaucoma Diagnostics for Structure and Function$714,891
R01 · FY2016 · EY · contact PI
Novel Diagnostics with Optical Coherence Tomography$437,893
R01 · FY2016 · EY
Novel Glaucoma Diagnostics for Structure and Function$711,566
R01 · FY2015 · EY · contact PI
Novel Diagnostics with Optical Coherence Tomography$260,124
R01 · FY2015 · EY
Novel Glaucoma Diagnostics for Structure and Function$726,299
R01 · FY2014 · EY · contact PI
Novel Glaucoma Diagnostics for Structure and Function$702,923
R01 · FY2013 · EY · contact PI
Novel Glaucoma Diagnostics for Structure and Function$745,376
R01 · FY2012 · EY · contact PI
Novel Glaucoma Diagnostics for Structure and Function$755,924
R01 · FY2011 · EY · contact PI
Novel Glaucoma Diagnostics for Structure and Function$813,222
R01 · FY2010 · EY · contact PI
Novel Glaucoma Diagnostics for Structure and Function$464,778
R01 · FY2009 · EY · contact PI
Novel Glaucoma Diagnostics for Structure and Function$444,219
R01 · FY2008 · EY · contact PI
Novel Glaucoma Diagnostics for Structure and Function$442,118
R01 · FY2007 · EY · contact PI
Novel Glaucoma Diagnostics for Structure and Function$440,380
R01 · FY2006 · EY · contact PI
Novel Glaucoma Diagnostics for Structure and Function$474,365
R01 · FY2005 · EY
NOVEL GLAUCOMA DIAGNOSTICS FOR STRUCTURE AND FUNCTION$271,761
R01 · FY2004 · EY
NOVEL GLAUCOMA DIAGNOSTICS FOR STRUCTURE AND FUNCTION$284,970
R01 · FY2003 · EY
NOVEL GLAUCOMA DIAGNOSTICS FOR STRUCTURE AND FUNCTION$298,677
R01 · FY2002 · EY
NOVEL GLAUCOMA DIAGNOSTICS FOR STRUCTURE AND FUNCTION$299,003
R01 · FY2001 · EY
NOVEL GLAUCOMA DIAGNOSTICS FOR STRUCTURE AND FUNCTION$312,289
R01 · FY2000 · EY